ASCO

ASCO

ASCO

ASCO is the American Society of Clinical Oncology. Making a world of difference in cancer care.
Founded
1964
Follow us
Alexa global traffic share
Twitter followers
Team Size
200+
Employees
Location
Headquarters
Xconomy

Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More

Xconomy

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

MedCity News

GSK gives taste of data on multiple myeloma drug ahead of ASCO

Xconomy

Bio Roundup: ASCO Wrap, Bluebird's EU Tap, CRISPR Baby Risk & More

Xconomy

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

MedCity News

Sanofi's isatuximab shines in myeloma at ASCO, but where will it fit into treatment?

MedCity News

Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies

Xconomy

ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More

Health Science
MedCity News

bluebird shares recover after slump following ASCO CAR-T data presentation

Xconomy

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

Health
Xconomy

Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo

Health
MedCity News

Loxo Oncology's shares shoot up on early data slated for ASCO presentation

Xconomy

Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout

Health Science
BI Tech

DIGITAL HEALTH BRIEFING: ASCO's new partnerships aim to improve oncology care — MedStar Health provides digital tools fo...

Health
Xconomy

ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity

Robotics Health Science
Xconomy

On ASCO's Eve, Experts Fret Over Backlash to Cancer Combo Frenzy

Robotics Health Technology Science
The Motley Fool

CAR-T Drugmakers: The Big Winners at ASCO This Year?

Health
The Motley Fool

Biotech Buzz: ASCO Winners and Losers and Biogen's Discouraging Failure

Health
The Motley Fool

Immunomedics' ASCO Letdown

Stock markets Health
Xconomy

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Health Stock markets